<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17054" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Acanthosis Nigricans</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brady</surname>
            <given-names>Mark F.</given-names>
          </name>
          <aff>Alpert Medical School of Brown University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rawla</surname>
            <given-names>Prashanth</given-names>
          </name>
          <aff>Sovah Health, Martinsville, VA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mark Brady declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prashanth Rawla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17054.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives. This activity reviews the workup and treatment of acanthosis nigricans and highlights the role of the interprofessional team in evaluating and treating patients with acanthosis nigricans.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify some of the more common and some of the less common etiologies of acanthosis nigricans.</p></list-item><list-item><p>Describe the management of acanthosis nigricans, and list any further evaluation that should be considered.</p></list-item><list-item><p>Explain the pathophysiologic basis for acanthosis nigricans.</p></list-item><list-item><p>Articulate the role of interprofessional team members in evaluating and treating patients with acanthosis nigricans.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17054&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17054">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17054.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Acanthosis nigricans is a velvety, darkening of the skin that usually occurs in intertriginous areas. This hyperpigmentation has poorly defined borders, usually occurs in skin fold areas, such as the back of the neck, axilla, and groin, and may include thickening of the skin. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a&#x000a0;sign of internal malignancy. It can also occur with hormone disorders and with the use of certain medications like systemic glucocorticoids and oral contraceptives.<xref ref-type="bibr" rid="article-17054.r1">[1]</xref><xref ref-type="bibr" rid="article-17054.r2">[2]</xref><xref ref-type="bibr" rid="article-17054.r3">[3]</xref></p>
      </sec>
      <sec id="article-17054.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are multiple factors involved in the development&#x000a0;of acanthosis nigricans.<xref ref-type="bibr" rid="article-17054.r4">[4]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased circulating insulin activates keratinocyte insulin-like growth&#x000a0;factor (ILGF) receptors, particularly IGF-1. At high concentrations, insulin may displace IGF-1 from IGF binding protein. Increased circulating IGF may lead to keratinocyte and dermal fibroblast proliferation.</p>
          </list-item>
          <list-item>
            <p>Hereditary variants are associated with fibroblast growth factor defects.</p>
          </list-item>
          <list-item>
            <p>Increased transforming growth factor&#x000a0;(TGF) appears to be the mechanism for malignancy-associated acanthosis nigricans. TGF acts on epidermal tissue via the epidermal growth factor receptor.</p>
          </list-item>
        </list>
        <p><bold>Familial acanthosis nigricans:</bold> may arise as a result of an autosomal dominant trait, presenting at birth or during childhood. It occurs due to&#x000a0;mutations in fibroblast growth factor receptor 3 (FGFR3).<xref ref-type="bibr" rid="article-17054.r5">[5]</xref></p>
        <p><bold>Obesity-associated acanthosis nigricans:&#x000a0;</bold>Obesity is&#x000a0;one of the most common conditions associated with Acanthosis nigricans. Lesions are usually common in adulthood but can occur at any age. It was once labeled as &#x0201c;pseudoacanthosis nigricans." It may be associated with insulin resistance. Treating obesity with diet, weight reduction, or medications can result&#x000a0;in the revolvement of acanthosis nigricans.<xref ref-type="bibr" rid="article-17054.r6">[6]</xref><xref ref-type="bibr" rid="article-17054.r7">[7]</xref></p>
        <p><bold>Medications associated with acanthosis nigricans:&#x000a0;</bold>Multiple medications have been linked to Acanthosis nigricans. These include the use of&#x000a0;nicotinic acid, systemic glucocorticoids, diethylstilbestrol,&#x000a0;combined oral contraceptive pill, growth hormone therapy, estrogen, protease inhibitors, niacin, and injected insulin. Once the offending medication is stopped, acanthosis nigricans usually resolves.<xref ref-type="bibr" rid="article-17054.r8">[8]</xref><xref ref-type="bibr" rid="article-17054.r9">[9]</xref><xref ref-type="bibr" rid="article-17054.r10">[10]</xref>&#x000a0;</p>
        <p><bold>Acanthosis nigricans associated with endocrine dysfunction:</bold>&#x000a0;It is more insidious in onset,&#x000a0;less widespread, and patients are often obese. Insulin-resistance syndromes may be divided into type A (HAIR-AN) and type B syndromes. Type A syndromes present with hyperandrogenemia, insulin resistance, and Acanthosis nigricans. Type B syndrome usually occurs in females who have uncontrolled diabetes, ovarian hyperandrogenism, or autoimmune diseases like SLE, Sjogren syndrome, or scleroderma. Polycystic ovarian syndrome (PCOS) is associated with acanthosis nigricans. Insulin resistance and hyperandrogenism are seen in patients with PCOS.<xref ref-type="bibr" rid="article-17054.r11">[11]</xref></p>
        <p><bold>Acral acanthotic anomaly:</bold>&#x000a0;Refers to a variant of acanthosis nigricans limited to the elbows, knees, knuckles, and dorsal surfaces of the feet. It is common in individuals&#x000a0;who have dark skin.<xref ref-type="bibr" rid="article-17054.r12">[12]</xref></p>
        <p><bold>Malignant acanthosis nigricans syndrome:</bold>&#x000a0;Is associated with gastrointestinal adenocarcinomas and genitourinary cancers such as prostate, breast, and ovary. Lung cancer and lymphoma&#x000a0;rarely&#x000a0;are associated with acanthosis nigricans. Malignant acanthosis nigricans may precede, accompany, or follow the onset of internal cancer. Malignancy-associated acanthosis nigricans&#x000a0;usually&#x000a0;has a rapid onset and is accompanied by skin tags, multiple seborrheic keratoses (the sign of Leser-Trelat), or tripe palms.<xref ref-type="bibr" rid="article-17054.r13">[13]</xref><xref ref-type="bibr" rid="article-17054.r14">[14]</xref></p>
        <p><bold>Auto-immune acanthosis nigricans: </bold>Is associated with autoimmune disorders like&#x000a0;SLE, Sjogren's syndrome, scleroderma, or Hashimoto's&#x000a0;thyroiditis.<xref ref-type="bibr" rid="article-17054.r15">[15]</xref></p>
        <p><bold>Unilateral acanthosis nigricans:&#x000a0;</bold>Also called nevoid acanthosis nigricans. It is very rare and is inherited in an autosomal dominant fashion. Lesions occur unilaterally. Lesions present in infancy, childhood, or adulthood.<xref ref-type="bibr" rid="article-17054.r16">[16]</xref></p>
      </sec>
      <sec id="article-17054.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Acanthosis nigricans typically occurs in individuals younger than the age of 40 years and is associated with obesity, hypothyroidism, acromegaly, polycystic ovary disease, insulin-resistant diabetes, and Cushing and Addison diseases. Acanthosis nigricans is also associated with rare diseases such as pinealoma, Cushing disease, ovarian hyperthecosis, stromal luteoma, ovarian dermoid cysts, Prader-Willi syndrome, leprechaunism, lipoatrophic diabetes, pineal hyperplasia syndrome, and Alstrom syndrome.<xref ref-type="bibr" rid="article-17054.r17">[17]</xref><xref ref-type="bibr" rid="article-17054.r18">[18]</xref></p>
        <p>In the United States population, acanthosis nigricans is more common in Native Americans, African&#x000a0;Americans, and Hispanics when compared to Whites or Asian origin individuals.<xref ref-type="bibr" rid="article-17054.r19">[19]</xref><xref ref-type="bibr" rid="article-17054.r20">[20]</xref></p>
      </sec>
      <sec id="article-17054.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of acanthosis nigricans is likely related to growth factor levels and insulin-mediated activation of insulin-like growth factor (IGF) on keratinocytes and increased growth factor levels. The pathophysiological process behind acanthosis nigricans appears to be related to the proliferation of fibroblasts and the enhanced stimulation of epidermal keratinocytes.<xref ref-type="bibr" rid="article-17054.r21">[21]</xref></p>
        <p>In patients with benign acanthosis nigricans, evidence suggests that insulin&#x000a0;or an&#x000a0;insulin-like growth factor is enhancing the&#x000a0;propagation of epidermal cells. Other mediators that have been identified include fibroblast growth factor and tyrosine kinase receptors (epidermal growth factor receptor). High concentrations of insulin are thought to cause proliferative effects by binding to IGF-1 receptors. It is important to note that free IGF-1 levels&#x000a0;also&#x000a0;are high in people with metabolic syndrome, leading to faster cell differentiation and cell growth.</p>
        <p>Recently, both syndromic and familial forms of acanthosis nigricans have been observed.&#x000a0;Familial and syndromic forms of acanthosis nigricans have been identified.&#x000a0;Many other syndromes share similar features, such as hyperinsulinemia, craniosynostosis, and obesity.&#x000a0;These are&#x000a0;subdivided into insulin-resistant syndromes and fibroblast growth factor defects.</p>
        <p>Other insulin-resistant syndromes include Rabson Mendenhall syndrome, leprechaunism, Berardinelli-Seip syndrome, Dunningan syndrome, and Alstrom syndrome. Excessive friction or sweating&#x000a0;may also be playing a contributory role.</p>
        <p>In patients with malignant acanthosis nigricans, the most probable stimulating factor is secreted by the cancer cells. Two possibilities are&#x000a0;transforming growth factor and epidermal growth factor because both&#x000a0;have&#x000a0;high levels in people with gastric adenocarcinoma. Other reports indicate normalization&#x000a0;of urine transforming growth factor after surgical removal of a tumor,&#x000a0;followed by regression of the skin lesions.</p>
        <p>Usage of medications like insulin has also been implicated, most likely&#x000a0;due to the activation of IGF receptors. A few case reports on ectopic acanthosis nigricans in syndromic patients report&#x000a0;patient acquisition of the disorder after skin grafting from an affected site.</p>
      </sec>
      <sec id="article-17054.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histological exam will reveal papillomatosis, hyperkeratosis with minimal hyperpigmentation. The dermal papillae usually have an upward projection with thinning of the epidermis. There is usually no dermal inflammatory infiltrate.</p>
      </sec>
      <sec id="article-17054.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients usually present with an asymptomatic area of darkening and thickening of the skin, pruritus, and lesions that are velvety, hyperpigmented macules and patches and progress to palpable plaques. In approximately one-third of cases, malignant acanthosis nigricans presents with skin changes before any signs of cancer. In another one-third of cases, lesions arise simultaneously with the neoplasm. In the remaining one-third of cases, the skin findings manifest sometime after the diagnosis of cancer.</p>
        <p>In nearly&#x000a0;one-third of patients with malignant acanthosis nigricans, the skin changes usually occur before any clinical signs of the malignancy. In another one-third of patients, the skin lesions develop at the same time as the presentation of cancer. In the remaining patients, the skin features occur after cancer has developed. Malignant acanthosis nigricans can appear suddenly and&#x000a0;often&#x000a0;is associated with intense pruritus.</p>
        <p>The lesions of acanthosis nigricans typically occur in areas of skin folds like the groin, axilla, or posterior neck. In children, the most common site of acanthosis nigricans is the posterior neck. Rarely, acanthosis nigricans may occur on the mucous membranes of the nose, oral cavity, esophagus, or larynx. Women&#x000a0;also&#x000a0;may develop lesions on the nipple. Rare cases of acanthosis nigricans have been reported in the conjunctiva.</p>
        <p>In some patients, there&#x000a0;also&#x000a0;may be associated with skin tags in the same area. Nail changes like hyperkeratosis and leukonychia may be present. Clinically, it is not possible to differentiate the lesions of benign versus malignant acanthosis nigricans.</p>
      </sec>
      <sec id="article-17054.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Acanthosis nigricans is diagnosed clinically and confirmed with a skin biopsy. Blood tests, endoscopy, or X-rays may be required to eliminate diabetes or cancer. On biopsy, hyperkeratosis, leukocyte infiltration, epidermal folding, and melanocyte proliferation may be seen. The workup focuses on ruling out malignancy. Since the vast majority of cases are associated with insulin resistance and/or obesity, screening for diabetes and measuring&#x000a0;glycosylated hemoglobin is recommended.<xref ref-type="bibr" rid="article-17054.r22">[22]</xref><xref ref-type="bibr" rid="article-17054.r23">[23]</xref></p>
      </sec>
      <sec id="article-17054.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Acanthosis nigricans is not treatable. It may fade over time by treating the cause, insulin resistance. Controlling blood glucose levels through exercise and diet often improves symptoms. Topical fade creams can lighten skin in less severe cases. Acanthosis nigricans malignant may resolve if the causative tumor is removed&#x000a0;successfully.<xref ref-type="bibr" rid="article-17054.r24">[24]</xref><xref ref-type="bibr" rid="article-17054.r25">[25]</xref></p>
        <p>The goal of treatment is to treat the underlying disease. In the majority of patients, the treatment is done&#x000a0;only&#x000a0;for aesthetic reasons. In some patients, weight loss and correction of insulin resistance lower the burden of hyperkeratotic lesions. Acanthosis nigricans associated with insulin resistance can be treated with drugs such as metformin and rosiglitazone, which are insulin-sensitizing agents.<xref ref-type="bibr" rid="article-17054.r26">[26]</xref><xref ref-type="bibr" rid="article-17054.r4">[4]</xref></p>
        <p>All inciting agents and medications should be discontinued. One should make attempts to lower the lipid profile. Reports suggest that dietary fish and niacin may help.</p>
        <p>Dermatologists sometimes prescribe keratolytics, such as topical retinoids (e.g.&#x000a0;topical tretinoin 0.1% or a combination of&#x000a0;tretinoin 0.05%&#x000a0;and 12% ammonium lactate) and podophyllin.<xref ref-type="bibr" rid="article-17054.r27">[27]</xref><xref ref-type="bibr" rid="article-17054.r28">[28]</xref>&#x000a0;Topical vitamin D analogs (e.g.&#x000a0;calcipotriol (calcipotriene) 0.005%) act by decreasing keratinocyte proliferation and cause an improvement of the acanthosis nigricans lesions.<xref ref-type="bibr" rid="article-17054.r29">[29]</xref> The success of these treatments is variable. Other agents that have been tried include metformin and etretinate. In one report, octreotide also showed marked improvement in a patient with insulin resistance.<xref ref-type="bibr" rid="article-17054.r30">[30]</xref></p>
        <p>Melatonin can also improve cutaneous symptoms in obese patients with Acanthosis nigricans by improving the&#x000a0;inflammatory status and insulin sensitivity.<xref ref-type="bibr" rid="article-17054.r31">[31]</xref></p>
        <p>Cosmetic treatments that have been tried include using alexandrite laser, dermabrasion, and chemical peels.<xref ref-type="bibr" rid="article-17054.r32">[32]</xref> Surgical removal is the main treatment for malignant lesions.<xref ref-type="bibr" rid="article-17054.r33">[33]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17054.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Seborrhea</p>
          </list-item>
          <list-item>
            <p>Tinea</p>
          </list-item>
          <list-item>
            <p>Erythrasma</p>
          </list-item>
          <list-item>
            <p>Candidiasis</p>
          </list-item>
          <list-item>
            <p>Pellagra</p>
          </list-item>
          <list-item>
            <p>Ichthyosis</p>
          </list-item>
          <list-item>
            <p>Linear epidermal nevus</p>
          </list-item>
          <list-item>
            <p>Granular parakeratosis</p>
          </list-item>
          <list-item>
            <p>Cutaneous hyperpigmentation related to Addison disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17054.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with the benign form of acanthosis nigricans have few or no skin complications,&#x000a0;good prognosis, and potential for resolution with treatment. Complications can stem from underlying diseases like diabetes and insulin resistance. Prognosis in patients with the malignant form of acanthosis nigricans is poor as the malignancy is advanced usually at the time of diagnosis in these patients.</p>
      </sec>
      <sec id="article-17054.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications depend on the cause of acanthosis nigricans. Most cases of acanthosis nigricans are due to insulin resistance, but however serious complications like malignancy can also be associated with this condition.</p>
      </sec>
      <sec id="article-17054.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>A dermatology referral may be warranted if the diagnosis is uncertain. Referral&#x000a0;to an endocrinologist may be needed in patients with diabetes and other metabolic disorders.</p>
      </sec>
      <sec id="article-17054.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need to be educated that hyperpigmentation of the skin may not solely be a skin condition and should be evaluated further, especially if it occurs in middle-aged to elderly patients. Patients need to follow up with&#x000a0;their primary care physicians regarding any abnormal pigmentation&#x000a0;in their skin. Hyperpigmentation of the skin due to acanthosis nigricans can be treated and sometimes resolves with adequate treatment of the skin condition or treatment of the underlying condition. Patients need to be educated on identifying the risk factors and signs and symptoms of a malignant condition associated with acanthosis nigricans. Depression and low self-esteem can occur in patients with acanthosis nigricans and diagnosis and psychological treatment should be started early in these patients.<xref ref-type="bibr" rid="article-17054.r34">[34]</xref><xref ref-type="bibr" rid="article-17054.r35">[35]</xref></p>
      </sec>
      <sec id="article-17054.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Acanthosis nigricans is a common skin disorder, but when it presents, the diagnosis can often be difficult. The condition can be benign or malignant, and hence an interprofessional approach is necessary to make a prompt diagnosis. Healthcare workers in primary care, including nurse practitioners, should always refer the patient to a dermatologist if unsure about the rash. The overall prognosis for patients with the malignant form of acanthosis nigricans is poor, with an average survival of fewer than 24 months. Those with the benign form have an excellent prognosis, provided the condition causing it is treated. The majority of practitioners&#x000a0;are likely to see acanthosis nigricans in the younger population with insulin resistance; hence a referral&#x000a0;to an endocrinologist is recommended. Finally, patients should be educated that acanthosis nigricans is not a primary skin disorder but is usually due to an underlying condition. In many benign cases, just changing&#x000a0;diet and losing weight may lead to a cure.<xref ref-type="bibr" rid="article-17054.r36">[36]</xref><xref ref-type="bibr" rid="article-17054.r37">[37]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-17054.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17054&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17054">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/acanthosis-nigricans/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17054">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17054/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17054">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17054.s17">
        <fig id="article-17054.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Acanthosis Nigricans Contributed by Scott Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Acanthosis-nigricans" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17054.s18">
        <fig id="article-17054.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Axillary Acanthosis Nigricans <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="acanthosis__nigricans" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17054.s19">
        <fig id="article-17054.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Images of skin tags and their removal using the radio cautery in the area surrounding the neck region.
Also seen in the images Acanthosis Nigricans of the neck indicating the association of skin tags with diabetes and pre-diabetes Contributed by Dr. Amarendra Pandey</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Skin__Tag__Removal" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17054.s20">
        <fig id="article-17054.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Acanthosis nigricans SV1 A Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Acanthosis__nigricans__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17054.s21">
        <fig id="article-17054.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Acanthosis nigricans SV2 Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Acanthosis__nigricans__SV2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17054.s22">
        <title>References</title>
        <ref id="article-17054.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smid</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Modaff</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alade</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Legare</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Pauli</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans in achondroplasia.</article-title>
            <source>Am J Med Genet A</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>176</volume>
            <issue>12</issue>
            <fpage>2630</fpage>
            <page-range>2630-2636</page-range>
            <pub-id pub-id-type="pmid">30380187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozlu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uzuncakmak</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Tak&#x00131;r</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akdeniz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karadag</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study.</article-title>
            <source>North Clin Istanb</source>
            <year>2018</year>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-119</page-range>
            <pub-id pub-id-type="pmid">30374476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez-Saldivar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Guti&#x000e9;rrez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Trevi&#x000f1;o-Alvarez</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Flores</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Montes-Villarreal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>&#x000c1;lvarez-Villalobos</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Elizondo-Plazas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salcido-Montenegro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ocampo-Candiani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gonz&#x000e1;lez</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance.</article-title>
            <source>Dermatoendocrinol</source>
            <year>2018</year>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>e1471958</fpage>
            <pub-id pub-id-type="pmid">30279953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hermanns-L&#x000ea;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Scheen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pi&#x000e9;rard</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans associated with insulin resistance : pathophysiology and management.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2004</year>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-203</page-range>
            <pub-id pub-id-type="pmid">15186199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukuchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tatsuno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tokura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Familial acanthosis nigricans with p.K650T FGFR3 mutation.</article-title>
            <source>J Dermatol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-210</page-range>
            <pub-id pub-id-type="pmid">29068064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ng</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans in obese adolescents: prevalence, impact, and management challenges.</article-title>
            <source>Adolesc Health Med Ther</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">28031729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sadamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Imamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Higuchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koga</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Furue</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans with severe obesity, insulin resistance and hypothyroidism: improvement by diet control.</article-title>
            <source>Dermatology</source>
            <year>1999</year>
            <volume>198</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-6</page-range>
            <pub-id pub-id-type="pmid">10325466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stals</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vercammen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morren</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans caused by nicotinic acid: case report and review of the literature.</article-title>
            <source>Dermatology</source>
            <year>1994</year>
            <volume>189</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-6</page-range>
            <pub-id pub-id-type="pmid">8075456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mellor-Pita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yebra-Bango</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alfaro-Mart&#x000ed;nez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors.</article-title>
            <source>Clin Infect Dis</source>
            <year>2002</year>
            <month>Mar</month>
            <day>01</day>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>716</fpage>
            <page-range>716-7</page-range>
            <pub-id pub-id-type="pmid">11823959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleming</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous insulin reaction resembling acanthosis nigricans.</article-title>
            <source>Arch Dermatol</source>
            <year>1986</year>
            <month>Sep</month>
            <volume>122</volume>
            <issue>9</issue>
            <fpage>1054</fpage>
            <page-range>1054-6</page-range>
            <pub-id pub-id-type="pmid">3527077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Khanijow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cedars</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Huddleston</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pasch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zane</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Shinkai</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.</article-title>
            <source>JAMA Dermatol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>152</volume>
            <issue>4</issue>
            <fpage>391</fpage>
            <page-range>391-8</page-range>
            <pub-id pub-id-type="pmid">26720591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anand</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acral acanthosis nigricans (acral acanthotic anomaly).</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>5</volume>
            <issue>Suppl 2</issue>
            <fpage>S140</fpage>
            <page-range>S140-1</page-range>
            <pub-id pub-id-type="pmid">25593810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>XK</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hyperpigmentation in the skin folds.</article-title>
            <source>BMJ</source>
            <year>2018</year>
            <month>Jan</month>
            <day>18</day>
            <volume>360</volume>
            <fpage>j5729</fpage>
            <pub-id pub-id-type="pmid">29348270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>YL</given-names>
              </name>
            </person-group>
            <article-title>Malignant acanthosis nigricans: an early diagnostic clue for gastric adenocarcinoma.</article-title>
            <source>World J Surg Oncol</source>
            <year>2017</year>
            <month>Nov</month>
            <day>25</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>208</fpage>
            <pub-id pub-id-type="pmid">29178944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kondo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Umegaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Terao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murota</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katayama</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>A case of generalized acanthosis nigricans with positive lupus erythematosus-related autoantibodies and antimicrosomal antibody: autoimmune acanthosis nigricans?</article-title>
            <source>Case Rep Dermatol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-91</page-range>
            <pub-id pub-id-type="pmid">22649336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gayen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Gharami</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Unilateral nevoid acanthosis nigricans: Uncommon variant of a common disease.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>5</volume>
            <issue>Suppl 1</issue>
            <fpage>S40</fpage>
            <page-range>S40-3</page-range>
            <pub-id pub-id-type="pmid">25506563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karada&#x0011f;</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Danarti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Al-Khuzaei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans and the metabolic syndrome.</article-title>
            <source>Clin Dermatol</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-53</page-range>
            <pub-id pub-id-type="pmid">29241752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Rojano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pizano-Z&#x000e1;rate</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Jim&#x000e9;nez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000e1;mano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Portillo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acantosis nigricansis associated with risk factors related to cardiovascular disease in Mexican children with obesity.</article-title>
            <source>Nutr Hosp</source>
            <year>2016</year>
            <month>Sep</month>
            <day>20</day>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>570</fpage>
            <pub-id pub-id-type="pmid">27759974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kong</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Rhyne</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Urias-Sandoval</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cardinali</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Weller</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Skipper</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Parnes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McPherson</surname>
                <given-names>L</given-names>
              </name>
              <collab>PRIME Net Clinicians</collab>
            </person-group>
            <article-title>Acanthosis Nigricans: high prevalence and association with diabetes in a practice-based research network consortium--a PRImary care Multi-Ethnic network (PRIME Net) study.</article-title>
            <source>J Am Board Fam Med</source>
            <year>2010</year>
            <season>Jul-Aug</season>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>476</fpage>
            <page-range>476-85</page-range>
            <pub-id pub-id-type="pmid">20616290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Keil</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Pathomvanich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uwaifo</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Sebring</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Yanovski</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children.</article-title>
            <source>J Pediatr</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>138</volume>
            <issue>4</issue>
            <fpage>474</fpage>
            <page-range>474-80</page-range>
            <pub-id pub-id-type="pmid">11295708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lause</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kamboj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fernandez Faith</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Dermatologic manifestations of endocrine disorders.</article-title>
            <source>Transl Pediatr</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>300</fpage>
            <page-range>300-312</page-range>
            <pub-id pub-id-type="pmid">29184811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Guti&#x000e9;rrez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salcido-Montenegro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gonz&#x000e1;lez</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For.</article-title>
            <source>Diabetes Ther</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>435</fpage>
            <page-range>435-438</page-range>
            <pub-id pub-id-type="pmid">29209995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez-Saldivar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Guti&#x000e9;rrez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ocampo-Candiani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gonz&#x000e1;lez</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Flores</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management.</article-title>
            <source>Dermatol Ther (Heidelb)</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-51</page-range>
            <pub-id pub-id-type="pmid">27921251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charnvises</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weerakiet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tingthanatikul</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wansumrith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chanprasertyothin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rojanasakul</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>161</fpage>
            <page-range>161-4</page-range>
            <pub-id pub-id-type="pmid">16335908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>NU</given-names>
              </name>
              <name>
                <surname>Roach</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alinia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Current treatment options for acanthosis nigricans.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>407</fpage>
            <page-range>407-413</page-range>
            <pub-id pub-id-type="pmid">30122971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benavides</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment options in insulin resistance obesity-related acanthosis nigricans.</article-title>
            <source>Ann Pharmacother</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>1090</fpage>
            <page-range>1090-4</page-range>
            <pub-id pub-id-type="pmid">18492785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darmstadt</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Yokel</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Treatment of acanthosis nigricans with tretinoin.</article-title>
            <source>Arch Dermatol</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>127</volume>
            <issue>8</issue>
            <fpage>1139</fpage>
            <page-range>1139-40</page-range>
            <pub-id pub-id-type="pmid">1863071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blobstein</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity.</article-title>
            <source>Cutis</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-4</page-range>
            <pub-id pub-id-type="pmid">12553628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gregoriou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anyfandakis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kontoleon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Christofidou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rigopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kontochristopoulos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans associated with primary hypogonadism: successful treatment with topical calcipotriol.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2008</year>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>373</fpage>
            <page-range>373-5</page-range>
            <pub-id pub-id-type="pmid">18608738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phiske</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>An approach to acanthosis nigricans.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>239</fpage>
            <page-range>239-49</page-range>
            <pub-id pub-id-type="pmid">25165638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gusdon</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Melatonin Treatment Improves Insulin Resistance and Pigmentation in Obese Patients with Acanthosis Nigricans.</article-title>
            <source>Int J Endocrinol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>2304746</fpage>
            <pub-id pub-id-type="pmid">29706998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenbach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ram</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Acanthosis nigricans of the axillae using a long-pulsed (5-msec) alexandrite laser.</article-title>
            <source>Dermatol Surg</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>8</issue>
            <fpage>1158</fpage>
            <page-range>1158-60</page-range>
            <pub-id pub-id-type="pmid">15274711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roychowdhury</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clearance of acanthosis nigricans associated with insulinoma following surgical resection.</article-title>
            <source>QJM</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>101</volume>
            <issue>11</issue>
            <fpage>899</fpage>
            <page-range>899-900</page-range>
            <pub-id pub-id-type="pmid">18669553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of depressive symptoms in obese patients with or without acanthosis nigricans.</article-title>
            <source>Hormones (Athens)</source>
            <year>2015</year>
            <season>Jul-Sep</season>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>417</fpage>
            <page-range>417-24</page-range>
            <pub-id pub-id-type="pmid">26188226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pirgon</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>Sandal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>G&#x000f6;k&#x000e7;en</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bilgin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>D&#x000fc;ndar</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Social anxiety, depression and self-esteem in obese adolescent girls with acanthosis nigricans.</article-title>
            <source>J Clin Res Pediatr Endocrinol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-8</page-range>
            <pub-id pub-id-type="pmid">25800478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kong</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sussman</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Skipper</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hsi</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Rhyne</surname>
                <given-names>RL</given-names>
              </name>
              <collab>RIOS Net Clinicians</collab>
            </person-group>
            <article-title>Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.</article-title>
            <source>Ann Fam Med</source>
            <year>2007</year>
            <season>May-Jun</season>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-8</page-range>
            <pub-id pub-id-type="pmid">17548847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17054.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daitchman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vermeulen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Acanthosis nigricans among women with gestational diabetes mellitus and risk of adverse pregnancy outcomes.</article-title>
            <source>Diabetes Care</source>
            <year>2008</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>e30</fpage>
            <pub-id pub-id-type="pmid">18268069</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
